Are results this Thursday? Thanks |
It is the forward p/e that counts as the eps for 2023 will be around £3,60 but then could be over £4 in the current year. It was just £2.31 in 2022 so that kind of growth is worth paying up for |
Wow it just wants to keep giving , this one. £110 gave no resistance. SURELY it must be peaking?? P/E is 60 now. |
Stormed through £100+... |
I've held these since 2009 paying £1.38. I have reduced over the years and now have about a quarter of my original number. They now yield 62% at cost, even though the yield hardly ever goes above 1%. Since I purchased the CAGR has been about 34% which is pretty amazing. Well done to Mr Circurel and his team. |
NK104...you stated...
I worked out today that with dividends I've made a profit of £9,900 in total down the years. And that's all thanks to the original posters like davidosh who alerted me to JDG.
Think I might buy some for my Isa!
It is certainly a pleasure to know others have gained measurably from investing in JDG and the benefit of David Cicurel coming to Mello over the past 15 years. DC always insisted on returning to our monthly Mello dinners when the results came out and he still features regularly in our virtual shows. I will try to get him to join us on our Results show on the 21st March. We will have at least six companies on that one.
Did you attend one of the Beckenham dinners?
Any Mello investors who bought at £1.78 when David Cicurel first came to Beckenham and held on tight with reinvested dividends would now have well over 100x their original investment |
some chunky trades today seem to be driving the share price higher and higher |
Judges Scientific (JDG) FY23 results webinar
Thursday, 21 March, 4:45pm
David Cicurel, Chief Executive Officer, Brad Ormsby, Chief Financial Officer, Mark Lavelle, Chief Operating Officer and Tim Prestidge, Group Business Development Director will host an online investor presentation covering the financial year ended 31 December 2023, followed by Q&A.
Register here: bit.ly/JDG_FY23_results_webinar |
A £100+ new high in the works? |
Today I sold the last of my JDG from my share account.
It was originally bought at the princely sum of £4.80 for 210 shares in early March 2012, i.e. just over a grand in total. And I kicked my self for not getting in a few days earlier.
Never bought more, though I should have. Sold some thinking they were expensive...and regreted it.
Anyway, the last have gone at £92 to make sure my CGT allowance for the year will be used up and that i stay below the incoming £500 dividend limit.
I worked out today that with dividends I've made a profit of £9,900 in total down the years. And that's all thanks to the original posters like davidosh who alerted me to JDG.
Think I might buy some for my Isa! |
well not really but JDG isn't a cheap stock so maybe folk are shedding rather than buying. AIM is littered with good company's shares getting hammered. It's not specific to the stock it's widespread risk aversion. |
Any ideas why the big fall in SP? |
Judges Scientific (JDG) Half Year 2023 results presentation - September 23
David Cicurel, CEO, Brad Ormsby, CFO, Mark Lavelle, COO and Tim prestige, Group Business Development Director present Half Year results for the six months ended 30th June 2023, followed by Q&A. Solid organic and acquisition growth and a 23% increase to interim dividend.
Watch the video here:
Or listen to the podcast here: |
"Machinery, Equipment & Components sector"...probably a decent dose of "technology" in their investee product portfolios I imagine. |
Judges Scientific posted unaudited Interims for the HY ended 30th June this morning. Revenue was up 32% to £61.3m, adjusted pre-tax profit was up 33% to £12.8m and adjusted basic EPS was up 23% to 152.8p. However, there was a statutory loss per share of 18.7p mainly due to acquisition-related costs. The Board expects that the Group will meet market expectations for the full year, for top-line growth of about 9% and bottom-line growth of about 18%. Valuation remains the obvious cloud with forward PE ratio at 23.4x leaving JDG ranked 30th out of 31 names in the Machinery, Equipment & Components sector. The share price has been drifting sideways for the past 6 months as it consolidates its longer run gains. There is a lot to like here for the longer run, but JDG may be a share to monitor in the near term....
...from WealthOracle |
From the July update 'The board expects the growth in Organic revenues to have produced double digit profit growth in H1'. Share price has been a bit weak recently, so maybe close to 10% rather than much higher. |
Judges Scientific (JDG) H1 results webinar
Wednesday, 20 September, 4:45pm
David Cicurel, Chief Executive Officer, Brad Ormsby, Chief Financial Officer, Mark Lavelle, Chief Operating Officer and Tim Prestidge, Group Business Development Director will present followed by Q&A.
Register here: bit.ly/JDG_H123_webinar |
Trading update:
"First Half Performance
The board expects the growth in Organic revenues to have produced double digit profit growth in H1, albeit at a slower rate than revenue growth as measures taken to compensate for the inflationary pressures observed in 2022 Q4 are progressively having an impact.
Outlook
The strong order book, and the general resilience of Judges' business give the board confidence that the current market expectations for the full year will be met." |
'Weak economic outlook and downbeat investor sentiment equals acquisition opportunities'
Questor share tip: Judge for yourself but it’s not rocket science that this is a fine time for mergers and purchases |
Shouldn't be as maximum earnout was disclosed in the Finals. |
I see that Geotek achieved the maximum earn out as announced today
Is this the reason for the recent strong SP? |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
